Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

9.08
-0.1700-1.84%
Post-market: 9.130.0460+0.51%19:30 EDT
Volume:1.80M
Turnover:16.48M
Market Cap:1.66B
PE:-89.02
High:9.34
Open:9.34
Low:9.04
Close:9.25
52wk High:11.33
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:0.28
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-170.07
PE(LYR):2,831.31

Loading ...

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike

Simply Wall St.
·
May 11

Oppenheimer Sticks to Its Buy Rating for Xeris Pharmaceuticals (XERS)

TIPRANKS
·
May 08

Stock Track | Xeris Pharmaceuticals Soars 5.02% in Pre-market on Strong Q1 Results and Raised Guidance

Stock Track
·
May 07

GUIDANCE: (XERS) Xeris Biopharma Expects 2026 Revenue Range $380M - $390M, vs. FactSet Est of $383.3M

MT Newswires Live
·
May 07

Earnings Flash (XERS) Xeris Biopharma Holdings Posts Q1 EPS $0.01, vs. FactSet Est of $0.01 Loss per Share

MT Newswires Live
·
May 07

Xeris Biopharma Holdings Q1 EPS $0.01 Beats $(0.00) Estimate, Sales $83.127M Beat $79.992M Estimate

Benzinga Earnings
·
May 07

BRIEF-Xeris Biopharma Q1 Net Income USD 2.234 Million

Reuters
·
May 07

Xeris Biopharma Holdings Inc - Tightens FY2026 Total Revenue Guidance to $380 Mln-$390 Mln

THOMSON REUTERS
·
May 07

Xeris Biopharma Q1 EPS USD 0.01

THOMSON REUTERS
·
May 07

Xeris Biopharma CLO Beth Hecht disposes 16,667 shares for $103,804.31

Reuters
·
May 02

Earning Preview: Xeris Pharmaceuticals Inc revenue is expected to increase by 38.85%, and institutional views are cautiously optimistic

Earnings Agent
·
Apr 30

Xeris Biopharma to report first-quarter results, host conference call

Reuters
·
Apr 23

Xeris Biopharma director Jeffrey Sherman to retire from board

Reuters
·
Apr 22

Record Profitability, 2026 Growth Outlook and Recorlev Patent Suit Might Change The Case For Investing In Xeris Biopharma Holdings (XERS)

Simply Wall St.
·
Apr 14